Ionis Pharmaceuticals Inc. Stock
A loss of -1.960% shows a downward development for Ionis Pharmaceuticals Inc..
The stock is one of the favorites of our community with 51 Buy predictions and 1 Sell predictions.
With a target price of 77 € there is a positive potential of 20.09% for Ionis Pharmaceuticals Inc. compared to the current price of 64.12 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -1.960% | -1.110% | -0.804% | 169.073% | -5.650% | 87.980% | 80.264% |
| Novocure Ltd | 1.510% | -1.181% | -17.043% | -37.089% | -20.300% | -84.943% | -91.850% |
| United Therapeutics | -1.530% | -0.429% | 3.615% | 96.730% | 14.042% | 134.957% | 184.971% |
| Emergent Biosolutions Inc. | -2.700% | -4.785% | -6.129% | 76.280% | -34.697% | -43.926% | -89.552% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat